Nomura Holdings
GBT

Nomura Holdings’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Nomura Holdings’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-161,309
Closed -$5.29M – 2071
2022
Q2 		$5.29M Buy
161,309
+43,109
+36% +$1.26M 0.02% 533
2022
Q1 		$4.24M Buy
+118,200
New +$3.53M 0.01% 674
2020
Q1 		– Sell
-30,640
Closed -$2.43M – 1298
2019
Q4 		$2.43M Buy
+30,640
New +$1.82M 0.01% 611

Other funds holding GBT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Nomura Holdings's GBT Position: Q3 2022 in Review

Nomura Holdings sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2022, closing a stake of 161,309 shares — an estimated $5.29M sold.

Nomura Holdings first reported a position in GBT in Q4 2019 and held it in 3 quarters. The position peaked at $5.29M in Q2 2022. 247 funds tracked by Wall St. Rank hold GBT as of Q3 2022.

  • Nomura Holdings reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2022 after selling out during the quarter.
  • Nomura Holdings sold 161,309 Global Blood Therapeutics, Inc. shares in Q3 2022, an estimated $5.29M.
  • Nomura Holdings first reported a position in Global Blood Therapeutics, Inc. in Q4 2019 and held it in 3 quarters.
  • Nomura Holdings's Global Blood Therapeutics, Inc. position peaked at $5.29M in Q2 2022.
  • 247 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2022.

Based on Nomura Holdings's 13F filing for Q3 2022, filed 15 Nov 2022.